source
- Marrow Therapeutics raises $173M to develop bone-marrow-targeted gene therapies for blood disordersMarrow Therapeutics announced a $173 million financing round, combining a $53 million Series A led by founder Scion Life Sciences and venBio with a $120 million Series B led by OrbiMed. The compan…
- EU regulators and industry discuss streamlining combination product oversight at summitAt the AFDO/RAPS Combination Products Summit, a panel of European regulators and industry representatives met to explore ways to simplify the regulatory pathway for combination products in the EU.…